Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Auxilium Pharmaceuticals, Inc.    AUXL   US05334D1072

 SummaryQuotesChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
12/15/2014 12/16/2014 12/17/2014 12/18/2014 12/19/2014 Date
32.755(c) 32.75(c) 33.47(c) 34.025(c) 34.7(c) Last
2 324 643 1 237 242 1 545 540 1 688 498 2 315 440 Volume
-1.07% -0.02% +2.20% +1.66% +1.98% Change
More quotes
Company
Auxilium Pharmaceuticals, Inc. is a specialty biopharmaceutical company.It focuses on developing and marketing products to predominantly specialist audiences, such as urologists, endocrinologists, certain targeted primary care physicians, hand surgeons, subsets of orthopedic, general, and plastic... 
Sector
Pharmaceuticals
Calendar
01/27 | 08:30amShareholder meeting
More about the company
Surperformance© ratings of Auxilium Pharmaceuticals,
Trading Rating : - Investor Rating :
More Ratings
Chart AUXILIUM PHARMACEUTICALS,
Duration : Period :
Auxilium Pharmaceuticals,  Technical Analysis Chart | AUXL | US05334D1072 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 399 M
EBIT 2014 16,6 M
Net income 2014 -
Debt 2014 479 M
Yield 2014 -
Sales 2015 484 M
EBIT 2015 105 M
Net income 2015 -
Debt 2015 364 M
Yield 2015 -
PER 2014 -
PER 2015
EV / Sales 2014 5,63x
EV / Sales 2015 4,41x
Capitalization 1 770 M
More Financials
Latest news on AUXILIUM PHARMACEUTICALS,
1d ago AUXILIUM PHARMACEUTICALS : Change in Directors or Principal Officers (form 8-K)
3d ago AUXILIUM PHARMACEUTICALS : Announces Date for Special Meeting of Stockholders
4d ago AUXILIUM PHARMACEUTICALS : Other Events (form 8-K)
4d ago AUXILIUM PHARMACEUTICALS : Reports Stockholders Special Meeting
12/12 AUXILIUM PHARMACEUTICALS : Other Events, Financial Statements and Exhibits (form..
12/11 AUXILIUM PHARMACEUTICALS : Announces Date for Special Meeting of Stockholders
12/04 AUXILIUM PHARMACEUTICALS : Presents STENDRA Data At SMSNA Scientific Meeting
12/03 AUXILIUM PHARMACEUTICALS : Presents XIAFLEX For Peyronie's Disease Data At SMSNA..
More news
Sector news
14h ago AstraZeneca CEO says new Pfizer bid unlikely - Swedish daily DI
1d ago JAZZ PHARMACEUTICALS : Receives FDA Approval For Intravenous Administration Of E..
1d ago CUBIST PHARMACEUTICALS : FDA OKs Cubist antibiotic for serious infections
More sector news


Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF